These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37035207)

  • 1. Survival and prognostic factors in patients with synchronous multiple primary esophageal squamous cell carcinoma receiving definitive radiotherapy: A propensity score-matched analysis.
    Wang W; Liu X; Dang J; Li G
    Front Oncol; 2023; 13():1132423. PubMed ID: 37035207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.
    Lin Z; Chen YY; Liu CH; Panzuto F; Ramirez RA; Lang M; Kim H; Ding ZY
    J Gastrointest Oncol; 2023 Dec; 14(6):2309-2323. PubMed ID: 38196527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses.
    Shi Z; Zhu X; Ke S; Qiu H; Cai G; Zhangcai Y; Chen Y
    Radiother Oncol; 2021 Nov; 164():236-244. PubMed ID: 34627936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of sex on the prognosis of patients with esophageal squamous cell cancer underwent definitive radiotherapy: a propensity score-matched analysis.
    Luo HS; Xu HY; Du ZS; Li XY; Wu SX; Huang HC; Lin LX
    Radiat Oncol; 2019 May; 14(1):74. PubMed ID: 31046792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical analysis of 117 cases with synchronous multiple primary esophageal squamous cell carcinomas.
    Chen Z; Li S; He Z; Li G
    Korean J Intern Med; 2021 Nov; 36(6):1356-1364. PubMed ID: 29742891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival.
    Tian S; Ma R; Liu Y; Chen F; Huang X; Yang Q; Nian W; Fan Z
    Transl Cancer Res; 2024 Jun; 13(6):2971-2984. PubMed ID: 38988936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
    Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
    Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a prognostic nomogram for esophageal squamous cell carcinoma patients received radiotherapy based on clinical risk factors.
    Li Y; Shao X; Dai LJ; Yu M; Cong MD; Sun JY; Pan S; Shi GF; Zhang AD; Liu H
    Front Oncol; 2024; 14():1429790. PubMed ID: 39239271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nomogram for the predicting of survival in patients with esophageal squamous cell carcinoma undergoing definitive chemoradiotherapy.
    Wang P; Yang M; Wang X; Zhao Z; Li M; Yu J
    Ann Transl Med; 2021 Feb; 9(3):233. PubMed ID: 33708860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prognostic value of clinical-reproductive model in Chinese female patients with esophageal squamous cell carcinoma.
    Zhang DY; Ku JW; Zhao XK; Zhang HY; Song X; Wu HF; Fan ZM; Xu RH; You D; Wang R; Zhou RX; Wang LD
    World J Gastroenterol; 2022 Apr; 28(13):1347-1361. PubMed ID: 35645543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of a nomogram and the prognostic prediction value of patients with esophageal squamous cell carcinoma undergoing radical radiotherapy.
    Xiao L; Lyu J; Chen M; Wang L; Huang J; Wei Y; Li T
    Future Sci OA; 2022 Mar; 8(3):FSO781. PubMed ID: 35251695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy.
    Liu C; Han J; Han D; Huang W; Li B
    J Thorac Dis; 2023 Apr; 15(4):2116-2128. PubMed ID: 37197526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma.
    Liu JS; Huang Y; Yang X; Feng JF
    Am J Cancer Res; 2015; 5(7):2180-9. PubMed ID: 26328248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a nomogram to predict overall survival of T1 esophageal squamous cell carcinoma patients with lymph node metastasis.
    Yu J; Hu W; Yao N; Sun M; Li X; Wang L; Yang Y; Li B
    Transl Oncol; 2021 Aug; 14(8):101127. PubMed ID: 34020370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining the systemic inflammation response index and prognostic nutritional index to predict the prognosis of locally advanced elderly esophageal squamous cell carcinoma patients undergoing definitive radiotherapy.
    Yan K; Wei W; Shen W; Du X; Zhu S; Zhao H; Wang X; Yang J; Zhang X; Deng W
    J Gastrointest Oncol; 2022 Feb; 13(1):13-25. PubMed ID: 35284132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a novel prognostic model for patients with surgically resected esophageal squamous cell carcinoma.
    Hu H; Zhang J; Yan H; Qin C; Guo H; Liu T; Tang S; Zhou H
    Front Oncol; 2022; 12():955353. PubMed ID: 36059713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic prediction by a novel integrative inflammatory and nutritional score based on least absolute shrinkage and selection operator in esophageal squamous cell carcinoma.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Front Nutr; 2022; 9():966518. PubMed ID: 36438741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and toxicities of locally advanced esophageal squamous cell carcinoma patients treated with early thoracic radiation therapy after induction chemotherapy.
    Qiu J; Lin H; Yu Y; Ke D; Li H; Zheng H; Zheng Q; Wang Z; Lin M; Yang J; Liu L; Zhang M; Liu T; Wu Y; Li J; Lai J
    Int J Clin Oncol; 2023 Apr; 28(4):550-564. PubMed ID: 36735115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
    Feng J; Wang L; Wang L; Yang X; Lou G
    BMC Cancer; 2022 Mar; 22(1):284. PubMed ID: 35300627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.